Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N275540-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $49.90 | |
N275540-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $139.90 | |
N275540-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $239.90 | |
N275540-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $489.90 | |
N275540-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $799.90 |
Broad spectrum MMP inhibitor
Synonyms | N-hydroxy-2-[(4-methoxybenzene)(2-methylpropyl)sulfonamido]acetamide | AKOS040744915 | 9P3H27MP46 | mmp-3 inhibitor ii | 2-((4-Methoxyphenyl)sulfonyl-(2-methylpropyl)amino)-N-oxidanyl-ethanamide | CS-0077845 | N-hydroxy-N~2~-[(4-methoxyphenyl)sulfonyl]-N~ |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description |
NNGH is a stromelysin-1 (MMP-3) inhibitor. MMP-3 is both a direct transcriptional target and a necessary contributor of the Wnt/β-catenin signaling pathway. Matrix metalloproteinases (MMPs) play a well-defined role in later stages of tumor progression
|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]acetamide |
---|---|
INCHI | InChI=1S/C13H20N2O5S/c1-10(2)8-15(9-13(16)14-17)21(18,19)12-6-4-11(20-3)5-7-12/h4-7,10,17H,8-9H2,1-3H3,(H,14,16) |
InChi Key | JIRXORZYIXSWOB-UHFFFAOYSA-N |
Canonical SMILES | CC(C)CN(CC(=O)NO)S(=O)(=O)C1=CC=C(C=C1)OC |
Isomeric SMILES | CC(C)CN(CC(=O)NO)S(=O)(=O)C1=CC=C(C=C1)OC |
PubChem CID | 448002 |
Molecular Weight | 316.37 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2419527 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419528 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419529 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419530 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419531 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419536 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419537 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419538 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419545 | Certificate of Analysis | Aug 02, 2024 | N275540 |
H2419546 | Certificate of Analysis | Aug 02, 2024 | N275540 |
Solubility | Soluble in DMSO to 100 mM and in ethanol to 25 mM |
---|---|
Sensitivity | Moisture sensitive. |
1. Liang M et al.. (2021) Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy.. Transl Oncol, 14 (12): (101221). [PMID:34530193] |